Lorlatinib

PF-06463922 is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity.

Price Not Available 100 mg Lorlatinib Supplier Page

Catalog Number	T3061
Alternative Name(s)	PF-6463922 , PF-06463922 , Loratinib
Research Area	Immunology/Inflammation\|\|\|Angiogenesis\|\|\|Tyrosine Kinase/Adaptors\|\|\|Apoptosis
Molecular Formula	C21H19FN6O2
CAS#	1454846-35-5
Purity	99.93%
SMILES	c1cc(cc2c1C(=O)N(C)Cc1c(c3cc(O[C@@H]2C)c(nc3)N)c(n(n1)C)C#N)F
Size	100 mg
Supplier Page	https://www.targetmol.com/compound/Lorlatinib
Additional Information	https://www.targetmol.com/datasheet/T3061